EAM

Exome Asset Management Portfolio holdings

AUM $151M
1-Year Est. Return 46.2%
This Quarter Est. Return
1 Year Est. Return
+46.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
+$41.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
85
New
Increased
Reduced
Closed

Top Buys

1 +$5.44M
2 +$4.27M
3 +$3.75M
4
ARWR icon
Arrowhead Research
ARWR
+$3.6M
5
CVS icon
CVS Health
CVS
+$3.29M

Top Sells

1 +$3.18M
2 +$2.99M
3 +$2.93M
4
VSTM icon
Verastem
VSTM
+$2.49M
5
GERN icon
Geron
GERN
+$2.13M

Sector Composition

1 Healthcare 97.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GERN icon
26
Geron
GERN
$836M
$2.55M 1.54%
1,858,354
-1,556,023
CTMX icon
27
CytomX Therapeutics
CTMX
$669M
$2.38M 1.44%
+745,305
PEN icon
28
Penumbra
PEN
$11.8B
$2.28M 1.38%
9,000
GKOS icon
29
Glaukos
GKOS
$6.23B
$2.21M 1.34%
+27,143
LQDA icon
30
Liquidia Corp
LQDA
$2.99B
$2.14M 1.3%
94,235
+73,735
CNTA
31
Centessa Pharmaceuticals
CNTA
$4.42B
$2.13M 1.29%
88,024
-78,920
TXG icon
32
10x Genomics
TXG
$2.25B
$1.91M 1.16%
163,658
COR icon
33
Cencora
COR
$65.9B
$1.88M 1.14%
+6,000
SNDX icon
34
Syndax Pharmaceuticals
SNDX
$1.77B
$1.81M 1.1%
117,783
-190,515
WAY
35
Waystar Holding Corp
WAY
$6.57B
$1.78M 1.08%
46,900
UHS icon
36
Universal Health Services
UHS
$14.4B
$1.63M 0.98%
7,955
-2,145
ORIC icon
37
Oric Pharmaceuticals
ORIC
$1.07B
$1.45M 0.88%
+120,644
PRCT icon
38
Procept Biorobotics
PRCT
$2B
$1.42M 0.86%
+39,900
INSP icon
39
Inspire Medical Systems
INSP
$3.98B
$1.38M 0.84%
+18,600
QURE icon
40
uniQure
QURE
$1.33B
$1.29M 0.78%
+22,090
MLTX icon
41
MoonLake Immunotherapeutics
MLTX
$1.06B
$1.28M 0.77%
+178,084
AVTX icon
42
Avalo Therapeutics
AVTX
$318M
$1.27M 0.77%
+100,036
GOSS icon
43
Gossamer Bio
GOSS
$771M
$1.19M 0.72%
451,699
-646,300
ALMS
44
Alumis Inc
ALMS
$1.16B
$1.17M 0.71%
+292,770
UPB
45
Upstream Bio Inc
UPB
$1.5B
$977K 0.59%
+51,960
MBX
46
MBX Biosciences
MBX
$1.44B
$917K 0.56%
52,402
-10,674
FULC icon
47
Fulcrum Therapeutics
FULC
$482M
$909K 0.55%
98,799
-346,150
ESTA icon
48
Establishment Labs
ESTA
$2.06B
$537K 0.33%
13,100
ABUS icon
49
Arbutus Biopharma
ABUS
$850M
$343K 0.21%
75,484
REPL icon
50
Replimune Group
REPL
$832M
$308K 0.19%
73,614
-324,232